- Home
- TTD vs ILMN Comparison
TTD vs ILMN Comparison
Compare TTD & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTD
- ILMN
- Stock Information
- Founded
- TTD 2009
- ILMN 1998
- Country
- TTD United States
- ILMN United States
- Employees
- TTD N/A
- ILMN N/A
- Industry
- TTD Computer Software: Programming Data Processing
- ILMN Medical Specialities
- Sector
- TTD Technology
- ILMN Health Care
- Exchange
- TTD Nasdaq
- ILMN Nasdaq
- Market Cap
- TTD 21.2B
- ILMN 18.4B
- IPO Year
- TTD 2016
- ILMN 2000
- Fundamental
- Price
- TTD $39.78
- ILMN $118.71
- Analyst Decision
- TTD Buy
- ILMN Hold
- Analyst Count
- TTD 34
- ILMN 15
- Target Price
- TTD $82.39
- ILMN $114.93
- AVG Volume (30 Days)
- TTD 12.4M
- ILMN 2.0M
- Earning Date
- TTD 11-06-2025
- ILMN 10-30-2025
- Dividend Yield
- TTD N/A
- ILMN N/A
- EPS Growth
- TTD 42.00
- ILMN N/A
- EPS
- TTD 0.88
- ILMN 4.46
- Revenue
- TTD $2,790,505,000.00
- ILMN $4,288,000,000.00
- Revenue This Year
- TTD $18.17
- ILMN N/A
- Revenue Next Year
- TTD $16.55
- ILMN $2.22
- P/E Ratio
- TTD $47.62
- ILMN $27.05
- Revenue Growth
- TTD 20.82
- ILMN N/A
- 52 Week Low
- TTD $41.50
- ILMN $68.70
- 52 Week High
- TTD $141.53
- ILMN $153.06
- Technical
- Relative Strength Index (RSI)
- TTD 26.85
- ILMN 61.14
- Support Level
- TTD $41.77
- ILMN $117.10
- Resistance Level
- TTD $45.50
- ILMN $125.50
- Average True Range (ATR)
- TTD 1.97
- ILMN 5.47
- MACD
- TTD -0.74
- ILMN 0.34
- Stochastic Oscillator
- TTD 0.51
- ILMN 78.33
About TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.